China Nuokang Bio-Pharmaceutical Inc. Announces Change in CFO
June 15, 2012 08:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, June 15, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate "Going Private" Proposal
June 04, 2012 08:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, June 4, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports First Quarter 2012 Financial Results
May 23, 2012 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
1Q12 Revenue was RMB60.3 Million ($9.6 Million)
1Q12 Net Income was RMB0.7 Million ($0.1 Million)
1Q12 Non-GAAP Adjusted Net Income was RMB1.4 Million ($0.2 Million)
Live conference call to be...
China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going Private" Proposal
May 21, 2012 08:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, May 21, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. to Report First Quarter 2012 Financial Results
May 10, 2012 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, May 10, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Announces Receipt of "Going Private" Proposal
May 09, 2012 07:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, May 9, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
CORRECTING and REPLACING -- China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
March 14, 2012 23:59 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, March 14, 2012 (GLOBE NEWSWIRE) -- Following a release published earlier today by China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP), please note that subheading for the non-GAAP...
China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results
March 14, 2012 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
4Q11 Revenue was RMB57.0 Million ($9.1 Million)
4Q11 Non-GAAP Adjusted Net Loss was RMB6.3 Million ($1.0 million)
FY11 Revenue was RMB288.3 Million ($45.8 Million)
FY11 Non-GAAP Adjusted Net...
China Nuokang Bio-Pharmaceutical Inc. to Report Fourth Quarter and Full Year 2011 Financial Results
February 27, 2012 09:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Feb. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a fully integrated, China-based biopharmaceutical company focused on the...
China Nuokang Bio-Pharmaceutical Inc. Provides Update on Continued Restructuring Efforts
February 27, 2012 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Feb. 27, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a fully integrated, China-based biopharmaceutical company focused on the...